Type 1 diabetes: Current concepts in epidemiology, pathophysiology, clinical care, and research

Current Problems in Pediatric and Adolescent Health Care

Volumn 42, Issue 10, 2012, Pages 269-291

  Gan, Mary Joyce ^a   Albanese O'Neill, Anastasia ^a   Haller, Michael J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; AUTOANTIBODY; AZATHIOPRINE; C PEPTIDE; CANAKINUMAB; COLONY STIMULATING FACTOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOSE; GLUTAMATE DECARBOXYLASE 65; GLUTAMIC ACID DECARBOXYLASE AUTOANTIBODY; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN AUTOANTIBODY; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; INSULINOMA ASSOCIATED 2 AUTOANTIBODY; ISLET CELL AUTOANTIBODY; ISOPHANE INSULIN; OTELIXIZUMAB; PREDNISONE; RITUXIMAB; TEPLIZUMAB; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC TRANSPORTER 8;

ABSENCE OF SIDE EFFECTS; AUTOIMMUNE DISEASE; BRAIN EDEMA; CAREGIVER; CELL DESTRUCTION; CLINICAL FEATURE; CLINICAL RESEARCH; CONTINUOUS INFUSION; DIET THERAPY; DRUG WITHDRAWAL; ELECTIVE SURGERY; ENVIRONMENTAL FACTOR; EPIDEMIC; EXERCISE; FAMILY; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPERGLYCEMIA; HYPERGLYCEMIC HYPEROSMOLAR SYNDROME; HYPEROSMOLARITY; HYPOKALEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; LYMPHOCYTIC INFILTRATION; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

EID: 84867314173     PISSN: 15385442     EISSN: 15383199     Source Type: Journal    
DOI: 10.1016/j.cppeds.2012.07.002     Document Type: Article

References (89)

1. A.K. Foulis, C.N. Liddle, M.A. Farquharson, J.A. Richmond, R.S. Weir The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: A 25-year review of deaths in patients under 20 years of age in the United Kingdom Diabetologia 29 1986 267 274
2. J. Logothetopoulos, N. Valiquette, E. Madura, D. Cvet The onset and progression of pancreatic insulitis in the overt, spontaneously diabetic, young adult BB rat studied by pancreatic biopsy Diabetes 33 1984 33 36
3. J.W. Yoon, H.S. Jun Autoimmune destruction of pancreatic beta cells Am J Ther 12 2005 580 591
4. K.M. Gillespie, E.A. Gale, P.J. Bingley High familial risk and genetic susceptibility in early onset childhood diabetes Diabetes 51 2002 210 214
5. M.J. Redondo, P.R. Fain, G.S. Eisenbarth Genetics of type 1A diabetes Recent Prog Horm Res 56 2001 69 89
6. A.M. Hämäläinen, M. Knip Autoimmunity and familial risk of type 1 diabetes Curr Diab Rep 2 2002 347 353
7. M.J. Haller, M.A. Atkinson, D. Schatz Type 1 diabetes mellitus: Etiology, presentation, and management Pediatr Clin North Am 52 2005 1553 1578
8. W. Winter Diabetes autoimmunity F. Lifshitz, 5th Edition Pediatric Endocrinology Vol. 1 2007 Informa Healthcare USA, Inc New York, NY 83 99
9. W. Winter Autoimmune disorders that influence carbohydrate metabolism Clinical and Laboratory Evaluation of Human Autoimmune Diseases 2002 ASCP Press Chicago, IL 345 372
10. N. Maclaren, W. Riley, N. Skordis, M. Atkinson, R. Spillar, J. Silverstein Inherited susceptibility to insulin-dependent diabetes is associated with HLA-DR1, while DR5 is protective Autoimmunity 1 1988 197 205
11. C.J. Greenbaum, D.A. Schatz, D. Cuthbertson, A. Zeidler, G.S. Eisenbarth, J.P. Krischer Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: Identification by the diabetes prevention trial-type 1 J Clin Endocrinol Metab 85 2000 1255 1260
12. H.K. Akerblom, M. Knip Putative environmental factors in type 1 diabetes Diabetes Metab Rev 14 1998 31 67
13. The environmental determinants of diabetes in the young (TEDDY) study Ann N Y Acad Sci 1150 2008 1 13
14. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 32 Suppl 1 2009 S62 S67
15. D.M. Maahs, N.A. West, J.M. Lawrence, E.J. Mayer-Davis Epidemiology of type 1 diabetes Endocrinol Metab Clin North Am 39 2010 481 497
16. The DIAMOND Project Group Incidence and trends of childhood type 1 diabetes worldwide 1990-1999 Diabet Med 23 2006 857 866
17. A.D. Liese, R.B. D'Agostino Jr, R.F. Hamman, P.D. Kilgo, J.M. Lawrence, L.L. Liu The burden of diabetes mellitus among US youth: Prevalence estimates from the SEARCH for diabetes in youth study Pediatrics 118 2006 1510 1518
18. D. Dabelea, E.J. Mayer-Davis, G. Imperatore The value of national diabetes registries: SEARCH for diabetes in youth study Curr Diab Rep 10 2010 362 369
19. K. Vehik, R.F. Hamman, D. Lezotte, J.M. Norris, G. Klingensmith, C. Bloch Increasing incidence of type 1 diabetes in 0- to 17-year-old colorado youth Diabetes Care 30 2007 503 509
20. D. Dabelea, R.A. Bell, R.B. D'Agostino Jr, G. Imperatore, J.M. Johansen, B. Linder Incidence of diabetes in youth in the United States JAMA 297 2007 2716 2724
21. C.C. Patterson, G.G. Dahlquist, E. Gyürüs, A. Green, G. Soltész Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study Lancet 373 2009 2027 2033
22. R. Turner, I. Stratton, V. Horton, S. Manley, P. Zimmet, I.R. Mackay UK Prospective Diabetes Study Group UKPDS 25: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes Lancet 350 1997 1288 1293
23. A. Carlsson, G. Sundkvist, L. Groop, T. Tuomi Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA) J Clin Endocrinol Metab 85 2000 76 80
24. G. Soltesz, C.C. Patterson, G. Dahlquist Worldwide childhood type 1 diabetes incidence - What can we learn from epidemiology? Pediatr Diabetes 8 Suppl 6 2007 6 14
25. C. Lévy-Marchal, C.C. Patterson, A. Green Geographical variation of presentation at diagnosis of type I diabetes in children: The EURODIAB study Diabetologia 44 Suppl 3 2001 B75 B80
26. M.M. Jahromi, G.S. Eisenbarth Cellular and molecular pathogenesis of type 1A diabetes Cell Mol Life Sci 64 2007 865 872
27. M. Hummel, E. Bonifacio, S. Schmid, M. Walter, A. Knopff, A.G. Ziegler Brief communication: Early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents Ann Intern Med 140 2004 882 886
28. J.M. Barker, K.J. Barriga, L. Yu, D. Miao, H.A. Erlich, J.M. Norris Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes autoimmunity study in the young (DAISY) J Clin Endocrinol Metab 89 2004 3896 3902
29. A.G. Ziegler, M. Hummel, M. Schenker, E. Bonifacio Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: The 2-year analysis of the German BABYDIAB study Diabetes 48 1999 460 468
30. T. Orban, J.M. Sosenko, D. Cuthbertson, J.P. Krischer, J.S. Skyler, R. Jackson Pancreatic islet autoantibodies as predictors of type 1 diabetes in the diabetes prevention trial-type 1 Diabetes Care 32 2009 2269 2274
31. M. Neufeld, N.K. Maclaren, W.J. Riley, D. Lezotte, J.V. McLaughlin, J. Silverstein, A.L. Rosenbloom Islet cell and other organ-specific antibodies in U.S. Caucasians and blacks with insulin-dependent diabetes mellitus Diabetes 29 1980 589 592
32. L. Niskanen, J. Karjalainen, H. Sarlund, O. Siitonen, M. Uusitupa Five-year follow-up of islet cell antibodies in type 2 (non-insulin-dependent) diabetes mellitus Diabetologia 34 1991 402 408
33. K. Decochez, B. Keymeulen, G. Somers Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset Belgian diabetes registry Diabetes Care 23 2000 1072 1078
34. M.A. Atkinson, N.K. Maclaren, L. Holmes, D.W. Scharp, P.E. Lacy, W.J. Riley The natural history and predictive value of Mr 64,000 autoantibodies for insulin-dependent diabetes mellitus J Autoimmun 3 Suppl 1 1990 41 45
35. I.M. Libman, M. Pietropaolo, M. Trucco, J.S. Dorman, R.E. LaPorte, D. Becker Islet cell autoimmunity in white and black children and adolescents with IDDM Diabetes Care 21 1998 1824 1827
36. M.A. Atkinson, N.K. Maclaren, W.J. Riley, W.E. Winter, D.D. Fisk, R.P. Spillar Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 35 1986 894 898
37. W.E. Winter, D.A. Schatz Autoimmune markers in diabetes Clin Chem 57 2011 168 175
38. J.M. Wenzlau, K. Juhl, L. Yu The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes Proc Natl Acad Sci U S A 104 2007 17040 17045
39. J.M. Wenzlau, L.M. Frisch, T.J. Gardner, S. Sarkar, J.C. Hutton, H.W. Davidson Novel antigens in type 1 diabetes: The importance of ZnT8 Curr Diab Rep 9 2009 105 112
40. D.B. Dunger, M.A. Sperling, C.L. Acerini European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric endocrine society consensus statement on diabetic ketoacidosis in children and adolescents Pediatrics 113 2004 e133 e140
41. C.P. Mahoney, B.W. Vlcek, M. DelAguila Risk factors for developing brain herniation during diabetic ketoacidosis Pediatr Neurol 21 1999 721 727
42. N. Glaser, P. Barnett, I. McCaslin Risk factors for cerebral edema in children with diabetic ketoacidosis The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics N Engl J Med 344 2001 264 269
43. C.M. McDonnell, C.C. Pedreira, B. Vadamalayan, F.J. Cameron, G.A. Werther Diabetic ketoacidosis, hyperosmolarity and hypernatremia: Are high-carbohydrate drinks worsening initial presentation? Pediatr Diabetes 6 2005 90 94
44. P. Zeitler, A. Haqq, A. Rosenbloom, N. Glaser Hyperglycemic hyperosmolar syndrome in children: Pathophysiological considerations and suggested guidelines for treatment J Pediatr 158 2011 9 14 14.e11-12
45. S.N. Mehta, J.I. Wolfsdorf Contemporary management of patients with type 1 diabetes Endocrinol Metab Clin North Am 39 2010 573 593
46. S.P. Lyles, J.H. Silverstein, A.L. Rosenbloom Practical aspects of diabetes care F. LIfshitz, Pediatric Endocrinology Vol. 1 2007 Informa Healthcare USA, Inc. New York, NY 125 154
47. T.M. Wallace, N.M. Meston, S.G. Gardner, D.R. Matthews The hospital and home use of a 30-second hand-held blood ketone meter: Guidelines for clinical practice Diabet Med 18 2001 640 645
48. M.J. Haller, M.S. Stalvey, J.H. Silverstein Predictors of control of diabetes: Monitoring may be the key J Pediatr 144 2004 660 661
49. Effectiveness of continuous glucose monitoring in a clinical care environment: Evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial Diabetes Care 33 2010 17 22
50. T. Aye, J. Block, B. Buckingham Toward closing the loop: An update on insulin pumps and continuous glucose monitoring systems Endocrinol Metab Clin North Am 39 2010 609 624
51. O. Escobar, D. Becker Management of the child with type 1 diabetes F. Lifshitz, 5th edition Pediatric Endocrinology Vol. 1 2007 Informa Healthcare USA, Inc New York, NY 101 124
52. L. Laffel Sick-day management in type 1 diabetes Endocrinol Metab Clin North Am 29 2000 707 723
53. M.A. Atkinson, N.K. Maclaren, R. Luchetta Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy Diabetes 39 1990 933 937
54. A. Kupila, J. Sipilä, P. Keskinen Intranasally administered insulin intended for prevention of type 1 diabetes - A safety study in healthy adults Diabetes Metab Res Rev 19 2003 415 420
55. L.C. Harrison, M.C. Honeyman, C.E. Steele Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes Diabetes Care 27 2004 2348 2355
56. L.C. Harrison INIT II study web site, 2010 http://www.diabetestrials.org/ initii.html Accessed January 20, 2010
57. E. Bonifacio JDRF funded research: Pre-point, 2010 http://onlineapps. jdfcure.org/AbstractReport.cfm?gran-id=26014&abs-type=LAY Accessed January 20, 2009
58. T. Orban, K. Farkas, H. Jalahej Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy J Autoimmun 34 2010 408 415
59. R. Tisch, X.D. Yang, R.S. Liblau, H.O. McDevitt Administering glutamic acid decarboxylase to NOD mice prevents diabetes J Autoimmun 7 1994 845 850
60. J. Ludvigsson, M. Faresjö, M. Hjorth GAD treatment and insulin secretion in recent-onset type 1 diabetes N Engl J Med 359 2008 1909 1920
61. J. Silverstein, N. Maclaren, W. Riley, R. Spillar, D. Radjenovic, S. Johnson Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus N Engl J Med 319 1988 599 604
62. P.F. Bougnères, J.C. Carel, L. Castaño, C. Boitard, J.L. Chaussain, J.F. Bach Cyclosporin and childhood diabetes: preliminary findings of the Saint Vincent de Paul trial [in French] Journ Annu Diabetol Hotel Dieu 1987 181 186
63. G.S. Eisenbarth, S. Srikanta, R. Jackson Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus Diabetes Res 2 1985 271 276
64. K.C. Herold, J.A. Bluestone, A.G. Montag Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody Diabetes 41 1992 385 391
65. N.A. Sherry, W. Chen, J.A. Kushner Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells Endocrinology 148 2007 5136 5144
66. B. Keymeulen, E. Vandemeulebroucke, A.G. Ziegler Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes N Engl J Med 352 2005 2598 2608
67. M.J. Haller, D.A. Schatz CD3-antibody therapy in new-onset type 1 diabetes mellitus N Engl J Med 353 2005 2086 2087 [Author reply: 2086-7]
68. Y. Xiu, C.P. Wong, J.D. Bouaziz B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions J Immunol 180 2008 2863 2875
69. P. Fiorina, A. Vergani, S. Dada Targeting CD22 reprograms B-cells and reverses autoimmune diabetes Diabetes 57 2008 3013 3024
70. C.E. Rudd, A. Taylor, H. Schneider CD28 and CTLA-4 coreceptor expression and signal transduction Immunol Rev 229 2009 12 26
71. M. Korolija, I.P. Renar, M. Hadzija Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with type 1 diabetes in Croatians Diabetes Res Clin Pract 86 2009 e54 e57
72. M. Mohty Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond Leukemia 21 2007 1387 1394
73. R. Saccardi, T. Kozak, C. Bocelli-Tyndall Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database Mult Scler 12 2006 814 823
74. A. Fassas, A. Anagnostopoulos, A. Kazis Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: First results of a pilot study Bone Marrow Transplant 20 1997 631 638
75. N. Frickhofen, H. Heimpel, J.P. Kaltwasser, H. Schrezenmeier Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of a plastic anemia Blood 101 2003 1236 1242
76. J. Kool, R.J. de Keizer, C.E. Siegert Antithymocyte globulin treatment of orbital Wegener granulomatosis: A follow-up study Am J Ophthalmol 127 1999 738 739
77. P.A. McSweeney, R.A. Nash, K.M. Sullivan High-dose immunosuppressive therapy for severe systemic sclerosis: Initial outcomes Blood 100 2002 1602 1610
78. J.J. Molldrem, E. Leifer, E. Bahceci Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes Ann Intern Med 137 2002 156 163
79. M. Musso, F. Porretto, A. Crescimanno, F. Bondi, V. Polizzi, R. Scalone Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease Am J Hematol 66 2001 75 79
80. S. Rosenfeld, D. Follmann, O. Nunez, N.S. Young Antithymocyte globulin and cyclosporine for severe aplastic anemia: Association between hematologic response and long-term outcome JAMA 289 2003 1130 1135
81. R.J. Stratton, H. Wilson, C.M. Black Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma Rheumatology (Oxford) 40 2001 84 88
82. D.A. Schatz, W.J. Riley, J.H. Silverstein, D.J. Barrett Long-term immunoregulatory effects of therapy with corticosteroids and anti-thymocyte globulin Immunopharmacol Immunotoxicol 11 1989 269 287
83. F. Saudek, T. Havrdova, P. Boucek, L. Karasova, P. Novota, J. Skibova Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset Rev Diabet Stud 1 2004 80 88
84. C.E. Couri, M.C. Oliveira, A.B. Stracieri C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus JAMA 301 2009 1573 1579
85. M.J. Parker, S. Xue, J.J. Alexander Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice Diabetes 58 2009 2277 2284
86. J.C. Voltarelli, C.E. Couri, A.B. Stracieri Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus JAMA 297 2007 1568 1576
87. S.E. Gitelman, M.J. Haller, D. Schatz Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus JAMA 302 2009 624 author reply 624-5
88. M.J. Haller, C.H. Wasserfall, K.M. McGrail Autologous umbilical cord blood transfusion in very young children with type 1 diabetes Diabetes Care 32 2009 2041 2046
89. M.J. Haller, H.L. Viener, C. Wasserfall, T. Brusko, M.A. Atkinson, D.A. Schatz Autologous umbilical cord blood infusion for type 1 diabetes Exp Hematol 36 2008 710 715